The role of RNA binding proteins in heart development and congenital heart defects
RNA结合蛋白在心脏发育和先天性心脏缺陷中的作用
基本信息
- 批准号:10827567
- 负责人:
- 金额:$ 73.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-12 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:3&apos Untranslated RegionsAblationAddressAdhesionsAdvanced DevelopmentAffectAlternative SplicingAntisense OligonucleotidesAortaBindingCardiacCardiac MyocytesCardiac Surgery proceduresCardiovascular systemCell AdhesionCell ProliferationCell physiologyCellsCirculationCommon VentricleComplementary DNACongenital Heart DefectsCustomDefectDevelopmentDevelopmental ProcessDiseaseEmbryonic HeartEndothelial CellsEtiologyExhibitsExtracellular MatrixFocal AdhesionsFutureGene ExpressionGenerationsGenesGeneticGenetic studyGoalsHealthHeartHeart TransplantationHeart failureHuman GeneticsHypoplastic Left Heart SyndromeImpairmentInfantIntronsKnock-inKnockout MiceKnowledgeLeftLeft ventricular structureLengthLinkMediatingMesenchymalMitochondriaMitral ValveMolecularMusMyoblastsMyocardialNeurofibromin 2Operative Surgical ProceduresPathogenicityPathologyPatientsPhenotypePoly APolyadenylationProliferatingPropertyProtein IsoformsRNARNA-Binding ProteinsRegulationReportingRight ventricular structureRoleSeriesSideSignal PathwaySignal TransductionSiteSyndromeTechniquesTestingTherapeuticTissuesTranscriptWorkaortic valvecardiogenesiscell motilityclinically relevantconditional knockoutcongenital heart disorderdesigngene correctiongene functioninnovationinsightloss of functionloss of function mutationmRNA Precursormigrationmortalitymouse modelmutantnanoporenovelnovel therapeuticsprevent
项目摘要
ABSTRACT
Hypoplastic left heart syndrome (HLHS) is a congenital heart disease with a high mortality rate. Infants with
this syndrome are born with circulation problems due to hypoplasia of the left part of the heart that includes
aorta, left ventricle, mitral valve and aortic valve. Infants may need to undergo a series of open-heart surgeries
to restore systemic circulation. Even after the surgeries, these patients can develop heart failure and other
complications due to the overload on the right ventricle that serves as the single ventricle. Very little is known
about the etiology and pathogenic mechanisms of HLHS. Recent human genetic studies identified de novo
loss of function mutations in the RNA binding protein RBFOX2 that are linked to the HLHS phenotype. It is
currently unknown how RBFOX2 contributes to HLHS developmental defects. This is mainly because of our
lack of knowledge regarding the role of RBFOX2 in cardiovascular development and its target RNAs in the
embryonic heart. Using our Rbfox2 conditional knockout mouse model, which recapitulates several phenotypic,
cellular, and molecular features of HLHS, we will address these urgent and clinically relevant questions utilizing
genetic, molecular/cellular and state-of-the art custom designed sequencing and computational approaches.
Our main goal is to determine the mechanisms by which RBFOX2-regulated RNA networks contribute to
cardiovascular development and investigate their contributions to HLHS. Our work will determine the
underlying mechanisms of HLHS developmental defects caused by loss of RBFOX2. Ultimately, our findings
will advance development of innovative HLHS therapeutic strategies by restoring aberrant RBFOX2-regulated
gene expression in HLHS patients using modified antisense oligonucleotides in the future.
抽象的
左心发育不良综合征(HLHS)是一种死亡率很高的先天性心脏病。婴儿患有
这种综合征由于左心发育不全而先天性出现循环问题,其中包括
主动脉、左心室、二尖瓣和主动脉瓣。婴儿可能需要接受一系列心脏直视手术
以恢复全身循环。即使在手术后,这些患者也可能出现心力衰竭和其他症状
由于作为单心室的右心室超负荷而引起的并发症。知之甚少
关于HLHS的病因和发病机制。最近的人类遗传学研究从头发现
与 HLHS 表型相关的 RNA 结合蛋白 RBFOX2 的功能缺失突变。这是
目前尚不清楚 RBFOX2 如何导致 HLHS 发育缺陷。这主要是因为我们
缺乏关于RBFOX2在心血管发育中的作用及其靶RNA的了解
胚胎心脏。使用我们的 Rbfox2 条件敲除小鼠模型,该模型概括了几种表型,
HLHS 的细胞和分子特征,我们将利用这些紧迫的和临床相关的问题
遗传、分子/细胞和最先进的定制设计测序和计算方法。
我们的主要目标是确定 RBFOX2 调节的 RNA 网络促进的机制
心血管发育并研究它们对 HLHS 的贡献。我们的工作将决定
RBFOX2 缺失导致 HLHS 发育缺陷的潜在机制。最终,我们的发现
将通过恢复异常的 RBFOX2 调节来促进创新 HLHS 治疗策略的开发
未来使用修饰的反义寡核苷酸在 HLHS 患者中进行基因表达。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MUGE NESLIHAN KUYUMCU-MARTINEZ其他文献
MUGE NESLIHAN KUYUMCU-MARTINEZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MUGE NESLIHAN KUYUMCU-MARTINEZ', 18)}}的其他基金
The role of RNA binding proteins in heart development and congenital heart defects
RNA结合蛋白在心脏发育和先天性心脏缺陷中的作用
- 批准号:
10444318 - 财政年份:2022
- 资助金额:
$ 73.38万 - 项目类别:
MECHANISM OF MIS-SPLICING IN MYOTONIC DYSTROPHY 1
强直性肌营养不良 1 中的错误剪接机制
- 批准号:
7215638 - 财政年份:2005
- 资助金额:
$ 73.38万 - 项目类别:
MECHANISM OF MIS-SPLICING IN MYOTONIC DYSTROPHY 1
强直性肌营养不良 1 中的错误剪接机制
- 批准号:
6938706 - 财政年份:2005
- 资助金额:
$ 73.38万 - 项目类别:
MECHANISM OF MIS-SPLICING IN MYOTONIC DYSTROPHY 1
强直性肌营养不良 1 中的错误剪接机制
- 批准号:
7053377 - 财政年份:2005
- 资助金额:
$ 73.38万 - 项目类别:
相似海外基金
Muscle-Specific CRISPR/Cas9 Exon Skipping for Duchenne Muscular Dystrophy Therapeutics
肌肉特异性 CRISPR/Cas9 外显子跳跃用于杜氏肌营养不良疗法
- 批准号:
10679199 - 财政年份:2023
- 资助金额:
$ 73.38万 - 项目类别:
Modulation of RNA Binding Proteins in Xenobiotic-induced Hepatotoxicity
RNA 结合蛋白在异生素诱导的肝毒性中的调节
- 批准号:
10587498 - 财政年份:2023
- 资助金额:
$ 73.38万 - 项目类别:
High-throughput dissection of RNA localization regulatory elements
RNA 定位调控元件的高通量解析
- 批准号:
10749328 - 财政年份:2023
- 资助金额:
$ 73.38万 - 项目类别:
Gprasp2 expression identifies a deeply quiescent hematopoietic stem cells subset with superior stemness and self-renewal
Gprasp2 表达鉴定出具有卓越干性和自我更新能力的深度静止造血干细胞亚群
- 批准号:
10751567 - 财政年份:2023
- 资助金额:
$ 73.38万 - 项目类别: